NCT05204524 2022-01-24
Temozolomide for Injection Combined With Epirubicin in First-line Treatment of Leiomyosarcoma
ChineseAMS
Phase NA Unknown
ChineseAMS
NovoCure Ltd.
Seattle Children's Hospital
Hebei Yanda Hospital
Shandong Cancer Hospital and Institute